Pre-ICU training. 工作態度 會客時主動告知病情 病歷每天書寫 2 次 主動反應問題 接觸病人前後洗手.

Slides:



Advertisements
Similar presentations
Assisted Circulation MEDICAL MEDICAL  Drugs  EECP MECHANICAL  IABP ( Introaortic balloon pump)  VAD (Ventricular assist device)
Advertisements

 Cardiovascular System – Heart and Blood Vessels Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health.
M YOCARDIAL ISCHEMIA Prepared by: Dr. Nehad Ahmed.
Intra-aortic Balloon Pump (IABP)
By: ABDULRAHMAN ALSALMI INTRA AORTIC BALLOON PUMP CHIEF CARDIAC PERFUSIONIST KFMMC.
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
Cardioanaesthesia. Coronary artery disease O 2 delivery Coronary blood flow = directly related to coronary perfusion pressure (CPP) CPP = aortic diastolic.
SHOCK.
Innovative Minimally Invasive Circulatory Assist Device.
Cardiogenic Shock and Hemodynamics. Outline Overview of shock – Hemodynamic Parameters – PA catheter, complications – Differentiating Types of Shock Cardiogenic.
Clinic of Cardiovascular and Thorax Surgery Bad Rothenfelde, Germany
1 Cardiac Pathophysiology Part B. 2 Heart Failure The heart as a pump is insufficient to meet the metabolic requirements of tissues. Can be due to: –
Bio-Med 350 Normal Heart Function and Congestive Heart Failure.
CORONARY CIRCULATION DR. Eman El Eter.
Bio-Med 350 Complications of Acute M.I. Douglas Burtt, M.D.
Hemodynamic Monitoring By Nancy Jenkins RN,MSN. What is Hemodynamic Monitoring? It is measuring the pressures in the heart.
Valvular Heart Disease. Normal heart valves function to maintain the direction of blood flow through the atria and ventricles to the rest of the body.
Diagnostic Stress Testing
Ventricular Assist Devices Brian Schwartz, CCP February 25, 2003.
Cardiovascular management
CONCEPTS OF NORMAL HEMODYNAMICS AND SHOCK
Intra-Aortic Balloon Pump Counterpulsation
Arrow Intra-Aortic Balloon Pump
Indication and contra-indications for cardiac catheterization
 By the end of this lecture the students are expected to:  Understand the concept of preload and afterload.  Determine factors affecting the end-diastolic.
Valvular Heart Disease Part 2: Aortic Valve. Aortic stenosis (AS)
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Complications of Acute M.I.
Myocardial infarction My objectives are: Define MI or heart attack Identify people at risk Know pathophysiology of MI Know the sign & symptom Learn the.
Angina & Dysrhythmias. A & P OF THE CARDIAC SYSTEM Cardiac output  CO=SV(stroke volume) X HR(heart rate) Preload  Volume of blood in the ventricles.
Chapter 16 Assessment of Hemodynamic Pressures
Frank-Starling Mechanism
Congestive Heart Failure ADOPTED FROM: Jarrod Eddy, PGY2 Internal Medicine Sub-I Lecture Series ADOPTED FROM: Jarrod Eddy, PGY2 Internal Medicine Sub-I.
Nursing and heart failure
Cardiogenic Shock Dr. Belal Hijji, RN, PhD October 12 & 15, 2011.
Pt’s treated with B-blockers post infarction are seen to have a significant reduction in re-infraction.
Chapter 9 Heart. Review of Structure and Function The heart is divided into the systemic (left) and pulmonary (right) systems –The pulmonary system has.
Intra-Aortic Balloon Pump What it is and what it does
Dr. Sohail Bashir Sulehria
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
AB 1/03 Non-Coronary Intervention Circulatory Support Advanced Angioplasty 2003 Andreas Baumbach Bristol Royal Infirmary.
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
IABP- Instrumentation, Indications and Complications
 By the end of this lecture the students are expected to:  Explain how cardiac contractility affect stroke volume.  Calculate CO using Fick’s principle.
Ihab Alomari, MD, FACC Assistant professor – Interventional Cardiology University of California, Irvine Division of Cardiology Cath Lab Essentials : LV.
Terapie chirurgiche dell’Insufficienza Cardiaca
Intra-aortic baloon pumps what, who, why why why? Daniel Lovric Fellow, CVICU Auckland City Hospital Auckland Region ICU Study Day 30th October 2014.
Presented by Nai-Hsin Chi National Taiwan University Hospital
Complications of PCI by Dr Sh.Golmohammadzadeh Interventional cardiologist.
Measuring Blood Pressure Blood pressure is indicates your heart health Blood pressure is indicates your heart health It is determined by the contractions.
Conflict of Interest Baxter Research Grant Medtronic Research Grant
Drugs for Angina Pectoris
IABP Review and Competency
Lesson 11.2 congenital heart disease (CHF) Atherosclerosis
Mechanical Support of the Failing Cardiorespiratory System
ISCHEMIC HEART DISEASE
Improving Outcomes in Cardiogenic Shock
University of Chicago Medicine
Extracorporeal Life Support (ECLS)
Cardiovascular Dynamics
Intra-Aortic Balloon Pumps
Medical-Surgical Nursing: Concepts & Practice
Chapter 28 Management of Patients With Coronary Vascular Disorders
Mechanical Circulatory Support Devices HOSEIN PASANDI.
Pressure Wave Reflection at the Heart
Figure 6 The haemodynamic effects of
CIRCULATORY SYSTEM Characteristics and Treatment of Common Cardiac and Circulatory Disorders.
Intra-Aortic Balloon Pumps
Charanjit S. Rihal et al. JACC 2015;65:e7-e26
Presentation transcript:

Pre-ICU training

工作態度 會客時主動告知病情 病歷每天書寫 2 次 主動反應問題 接觸病人前後洗手

AMI EKG, cardiac enzyme serially check Aspirin, Plavix, Enoxaparin CXR ACEI and B-blocker 視情形給與 MONA Intervention 的時機 Heart echo

CHF with pulmonary edema Nitrate + Diuretics and keep I/O negative ACEI O2 Correct hypoalbuminemia Swan-ganz monitor, pending

Swan-ganz

Indication Shock D/D Monitor fluid and C/O and adjust medication

TPM

Indication Bradycardia with symptom and refractory to medication

IABP

Indication A. cardiogenic shock –Bridge to revascularization –Bridge to tertiary center B. Refractory unstable angina C. Acute MI cathter based perfusion D. High risk percutaneous revascularization E.End stage cardiomyopathy/bridge to heart transplantation

Indication G. Mechanical complication of acute MI. Acute MR and VSD H.decompensated aortic stenosis I. Refractory ventricular arrythmias J. Weaning from cardiopulmonary bypass /post operative pump failure

Contraindication A. Aortic dissection B. Abominal or thoracic aneurysm C. Severe peripheral vascular disease D. Descending aortic and peripheral vascular graft E. Coagulopathy or contraindication to heparin F. moderate to severe aortic insufficiency

Complication A. Vascular –Ischemia –Bleeding B. Infection C. Balloon rupture D. Balloon entrapment E. RBC and platelet destruction F. Others

Red line represents actual pressure tracing with an initial systolic waveform followed by an pump generated waveform and then the systolic waveform seen following a balloon waveform with reduced systolic pressure

Figure 1b. Early inflation. May result in premature closure of aortic valve, increase in LVEDV and LVEDP, increased afterload, increased myocardial oxygen demand

Late inflation. Results in sub-optimal coronary perfusion.

Early deflation. Sharp drop following diastolic augmentation. Diastolic augmentation sub-optimal. Results in sub-optimal coronary perfusion, potential for retrograde coronary and carotid blood flow, sub-optimal afterload reduction and increase myocardial oxygen demand.

Late deflation. Afterload reduction almost absent. Increased myocardial oxygen demand du to LV ejecting against a greater resistance and a prolonged isovolumic contraction phase. Increased afterload.